On July 29, Maiwei Biotech announced that it had reached a licensing agreement with Saudi Arabian biopharmaceutical company SVAXInc. for 9MW0813. According to the agreement, the two sides will carry out in-depth cooperation on the registration, production and commercialization of products in the Arab Gulf countries.

Zhitongcaijing · 4d ago
On July 29, Maiwei Biotech announced that it had reached a licensing agreement with Saudi Arabian biopharmaceutical company SVAXInc. for 9MW0813. According to the agreement, the two sides will carry out in-depth cooperation on the registration, production and commercialization of products in the Arab Gulf countries.